Literature DB >> 32950635

Differential expression profiling of transcripts of IDH1, CEA, Cyfra21-1, and TPA in stage IIIa non-small cell lung cancer (NSCLC) of smokers and non-smokers cases with air quality index.

Archana Mishra1, Neetu Singh2, Hari Shyam3, Mayank Jain3, Dinesh Kumar Sahu3, Pratap Shankar3, Nawazish Alam3, Anil Kumar3, Riddhi Jaiswal4, Shailendra Kumar5.   

Abstract

Smoking tobacco is the major hazard for lung cancer in Indian subcontinent especially men, compare to woman where, other important risk factors such as air pollutions are responsible. So, the aim of the study is to compare chronic smokers (CS) and non-smokers living in areas with air quality categorized as poor (AQI 201-300) or moderate (AQI 101-200). We measured the expression of non-small cell lung cancer (NSCLC) biomarkers;. IDH1, CEA, Cyfra21-1, and TPA through quantitative Real-Time PCR (qRT-PCR) and compared the levels of upregulation of the transcripts in stage IIIa NSCLC over control benign tissues among the smoking and AQI settings. Though the all biomarkers were significantly up-regulated in tumor tissues compared to control benign tissues, the fold change increase of IDH1 and CEA was highest in CS-poor/moderate AQI, followed by non-smokers-poor AQI and non-smokers moderate AQI. This indicates the aggressiveness and poor prognosis in CS living in either poor or moderate AQI areas. The level of Cyfra21-1 was lower in in the CS groups in comparison to non-smokers in the poor AQI area. This suggest higher Lung Squamous cell carcinoma histology in non-smokers living areas with poor AQI. Hence, we conclude that poor air quality can be as injurious for lung cancers as chronic smoking.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Air Quality Index; And TPA; CEA; Cyfra21-1; IDH1; Smoker and Non-smokers; Transcript-based biomarkers

Mesh:

Substances:

Year:  2020        PMID: 32950635     DOI: 10.1016/j.gene.2020.145151

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  3 in total

1.  Comprehensive Characterization of Stage IIIA Non-Small Cell Lung Carcinoma.

Authors:  Neetu Singh; Archana Mishra; Dinesh Kumar Sahu; Mayank Jain; Hari Shyam; Ratnesh Kumar Tripathi; Pratap Shankar; Anil Kumar; Nawazish Alam; Riddhi Jaiswal; Shailendra Kumar
Journal:  Cancer Manag Res       Date:  2020-11-20       Impact factor: 3.989

2.  Miniaturized microfluidic-based nucleic acid analyzer to identify new biomarkers of biopsy lung cancer samples for subtyping.

Authors:  Xue Lin; Zi-Hao Bo; Wenqi Lv; Zhanping Zhou; Qin Huang; Wenli Du; Xiaohui Shan; Rongxin Fu; Xiangyu Jin; Han Yang; Ya Su; Kai Jiang; Yuchen Guo; Hongwu Wang; Feng Xu; Guoliang Huang
Journal:  Front Chem       Date:  2022-08-29       Impact factor: 5.545

3.  The Effect of PD-1 Inhibitor Combined with Chemotherapy on the Level of Peripheral Blood T Lymphocytes among Patients with Non-Small-Cell Lung Cancer and Its Relationship with Prognosis.

Authors:  Yun Zhao; Jianbo He; Shaozhang Zhou; Ruiling Ning; Wenhua Zhao; Huilin Wang; Cuiyun Su; Wei Jiang; Xiaoning Zhong; Qitao Yu
Journal:  Comput Math Methods Med       Date:  2022-09-07       Impact factor: 2.809

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.